16-23186868-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001039.4(SCNN1G):c.317+280G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.208 in 151,952 control chromosomes in the GnomAD database, including 3,624 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.21 ( 3624 hom., cov: 32)
Consequence
SCNN1G
NM_001039.4 intron
NM_001039.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.816
Genes affected
SCNN1G (HGNC:10602): (sodium channel epithelial 1 subunit gamma) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the gamma subunit, and mutations in this gene have been associated with Liddle syndrome. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 16-23186868-G-A is Benign according to our data. Variant chr16-23186868-G-A is described in ClinVar as [Benign]. Clinvar id is 1265535.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.3 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.207 AC: 31486AN: 151832Hom.: 3606 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31486
AN:
151832
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.208 AC: 31534AN: 151952Hom.: 3624 Cov.: 32 AF XY: 0.208 AC XY: 15460AN XY: 74266 show subpopulations
GnomAD4 genome
AF:
AC:
31534
AN:
151952
Hom.:
Cov.:
32
AF XY:
AC XY:
15460
AN XY:
74266
Gnomad4 AFR
AF:
AC:
0.118113
AN:
0.118113
Gnomad4 AMR
AF:
AC:
0.306915
AN:
0.306915
Gnomad4 ASJ
AF:
AC:
0.245817
AN:
0.245817
Gnomad4 EAS
AF:
AC:
0.157976
AN:
0.157976
Gnomad4 SAS
AF:
AC:
0.222315
AN:
0.222315
Gnomad4 FIN
AF:
AC:
0.238953
AN:
0.238953
Gnomad4 NFE
AF:
AC:
0.234298
AN:
0.234298
Gnomad4 OTH
AF:
AC:
0.210701
AN:
0.210701
Heterozygous variant carriers
0
1240
2480
3719
4959
6199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
666
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at